Merck & Co Inc
XHAN:6MK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
XHAN:6MK
|
US |
|
D
|
Daiichi Life Group Inc
XMUN:QHH
|
JP |
|
E
|
Evoke PLC
XMUN:C8V
|
GI |
|
E
|
Elis SA
F:7EL
|
FR |
|
B2 Impact ASA
F:B28
|
NO |
|
Verbrec Ltd
ASX:VBC
|
AU |
Intrinsic Value
Is 6MK undervalued or overvalued?
See the intrinsic value estimate for 
Merck & Co Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Merck Does
Merck & Co. is a global drug company that makes prescription medicines, vaccines, and animal health products. Its best-known business is developing and selling branded drugs for cancer, infectious disease, diabetes, and other serious conditions. It also sells vaccines and medicines used by veterinarians and livestock producers.
- Headquarters
- United States of America US
- Employees
- 75 000
- IPO date
- Jan 1, 1941
Merck & has a wide economic moat
Legal protection for Merck’s medicines prevents rivals from freely selling copies, allowing it to earn more than it could in a market filled with cheaper alternatives. Its protected treatments span cancer, vaccines and other diseases, so this protection extends beyond a single medicine.
Read the full moat analysis
Revenue & Expenses Breakdown
Merck & Co Inc
Earnings Waterfall
Merck & Co Inc
The intrinsic value for Merck & Co Inc (6MK) under the Base Case is hidden EUR.
Compared with the current market price of 129.58 EUR, the stock appears hidden.
